Epimorphin was recently described as a mesenchymal factor modulating morphogenesis of murine mammary ducts, skin, liver, and lung in vitro. In this study epimorphin was analyzed in a human, pancreatic adenocarcinoma cell line (A818-6) which develops single layer epithelial hollow spheres resembling normal pancreatic ductal structures in vitro. Soluble 34- and 31-kD isoforms of epimorphin were found in the culture supernatant of A818-6 cells. In lysates of A818-6 cells we detected the 34-and 31-kD isoforms and the dimers, and in lysates of fibroblasts the 150-kD tetramers of epimorphin additionally. A neutralizing monoclonal antibody against epimorphin (MC-1) efficiently blocked the development of hollow sphere structures from A818-6 cells. Coculture of A818-6 cells with fibroblasts stimulated the development of hollow sphere structures in general and increased differentiation in 5–6-d-old hollow spheres. A818-6 hollow sphere development in the presence of fibroblasts was also blocked by MC-1. In this novel system for human duct-like differentiation of pancreatic epithelial cells, we provide evidence for an autocrine and paracrine function of epimorphin as a major mediator for morphogenesis.
Skip Nav Destination
Article navigation
5 March 2001
Article Contents
Article|
February 26 2001
Autocrine Stimulation of Human Pancreatic Duct–Like Development by Soluble Isoforms of Epimorphin in Vitro
Lasse Lehnert,
Lasse Lehnert
aMolecular Oncology, Department of General and Thoracic Surgery
Search for other works by this author on:
Markus M. Lerch,
Markus M. Lerch
cDepartment of Medicine B, Westfälische Wilhelms University, Münster 48149, Germany
Search for other works by this author on:
Yohei Hirai,
Yohei Hirai
dSumitomo Industries, Yokohama 244-8588, Japan
Search for other works by this author on:
Marie-Luise Kruse,
Marie-Luise Kruse
bFirst Department of Medicine, Laboratory for Molecular Gastroenterology and Hepatology, Christian-Albrechts University, Kiel 24105, Germany
Search for other works by this author on:
Wolff Schmiegel,
Wolff Schmiegel
eMedical Clinic, Knappschaftskrankenhaus, Ruhr, University of Bochum, Bochum 44780, Germany
Search for other works by this author on:
Holger Kalthoff
Holger Kalthoff
aMolecular Oncology, Department of General and Thoracic Surgery
Search for other works by this author on:
Lasse Lehnert
aMolecular Oncology, Department of General and Thoracic Surgery
Markus M. Lerch
cDepartment of Medicine B, Westfälische Wilhelms University, Münster 48149, Germany
Yohei Hirai
dSumitomo Industries, Yokohama 244-8588, Japan
Marie-Luise Kruse
bFirst Department of Medicine, Laboratory for Molecular Gastroenterology and Hepatology, Christian-Albrechts University, Kiel 24105, Germany
Wolff Schmiegel
eMedical Clinic, Knappschaftskrankenhaus, Ruhr, University of Bochum, Bochum 44780, Germany
Holger Kalthoff
aMolecular Oncology, Department of General and Thoracic Surgery
Abbreviations used in this paper: 3D, three-dimensional; bFGF, basic FGF; CAII, carbonic anhydrase II; EGFP, enhanced green fluorescent protein; HGF, hepatocyte growth factor; HRG, heregulin; IL, interleukin; KGF, keratinocyte growth factor; VSV-G, vesicular stomatitis virus glycoprotein.
Received:
July 26 2000
Revision Requested:
January 17 2001
Accepted:
January 22 2001
Online ISSN: 1540-8140
Print ISSN: 0021-9525
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Cell Biol (2001) 152 (5): 911–922.
Article history
Received:
July 26 2000
Revision Requested:
January 17 2001
Accepted:
January 22 2001
Citation
Lasse Lehnert, Markus M. Lerch, Yohei Hirai, Marie-Luise Kruse, Wolff Schmiegel, Holger Kalthoff; Autocrine Stimulation of Human Pancreatic Duct–Like Development by Soluble Isoforms of Epimorphin in Vitro. J Cell Biol 5 March 2001; 152 (5): 911–922. doi: https://doi.org/10.1083/jcb.152.5.911
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement